Target intelligence / Profile preview

RNA, U6 small nuclear 1312, pseudogene (RNU6-1312P)

Target
RNU6-1312P
Molecular classification
Pseudogene, Non-coding RNA, Processed pseudogene (derived from small nuclear RNA gene)
01

Overview

RNA, U6 small nuclear 1312, pseudogene (RNU6-1312P) is a genomic sequence in humans derived from the highly conserved U6 small nuclear RNA gene, a fundamental component of the spliceosomal machinery[1][3]. RNU6-1312P is a processed pseudogene, meaning it has lost its ability to produce a functional RNA or protein but persists in the genome as a non-coding fragment. The parental U6 snRNA orchestrates catalytic steps of intron removal in eukaryotic mRNA splicing[1][3]. Although some pseudogenes have regulatory functions in rare cases (such as microRNA sponge activities), RNU6-1312P is not documented to play any known functional, regulatory, or disease-related role, nor is it a molecular drug target[4]. It therefore represents a non-functional genetic remnant rather than a biologically or pharmacologically active molecule. If structured information is needed for biomedical targeting, this entry should be flagged as incorrect for use as a target.

Other names
RNU6-1312P
02

Mechanism of action

Not applicable; there are no known drugs or mechanisms targeting RNU6-1312P.

03

Biological functions

Processed pseudogenes like RNU6-1312P generally lack biological function.Parental gene U6 snRNA is essential for RNA splicing in the spliceosome.Possible rare functions (for processed pseudogenes): Competing endogenous RNA (ceRNA) activity (sponging miRNAs) in defective, disease-associated casesPossible rare functions (for processed pseudogenes): Antisense RNA activity (in very rare cases)
04

Disease associations

RNU6-1312P has no demonstrated disease role.No evidence linking RNU6-1312P to any disease.

Beyond the preview

Go deeper on RNA, U6 small nuclear 1312, pseudogene (RNU6-1312P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1312, pseudogene (RNU6-1312P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call